Nyumbani › Limfoma ya Seli za Mantle › Washington › Seattle
Majaribio ya kliniki ya Limfoma ya Seli za Mantle katika Seattle, WA
Masomo 12 ya Limfoma ya Seli za Mantle yanatafuta washiriki katika vituo vya Seattle na maeneo yake (ndani ya takriban maili 30). Fungua somo kuona nani anaweza kujiunga na jinsi ya kuwasiliana na timu ya utafiti.
Maandishi rasmi ya utafiti (Kiingereza)
Unavutia washiriki kwa utafiti hapa? Weka juu ya ukurasa huu — $99 kwa siku 30 →
A Study to Evaluate Safety, PK, PD and Efficacy of AZD5492, a T Cell-engaging Antibody Targeting CD20 in Subjects With R/R B-Cell Malignancies.
InaajiriHatua 1/2
- Research Site, Seattle
A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies
InaajiriHatua 1/2
- Fred Hutchinson Cancer Research Center, Seattle
A Study to Investigate the Safety of Novel Dose Ramp-up Schedule(s) When Initiating Sonrotoclax in Participants Treated for Blood Cancers.
InaajiriHatua 1/2
- Fred Hutchinson Cancer Research Center, Seattle
A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )
InaajiriHatua 1
- Swedish Cancer Institute (SCI), Seattle
This is a Phase 1 Study to Evaluate the Safety of LTZ-301 in Patients With Non-Hodgkin Lymphoma
InaajiriHatua 1
- Fred Hutchinson Cancer Center, Seattle
DALY II USA/ MB-CART2019.1 for DLBCL
InaajiriHatua 2
- Fred Hutchinson Cancer Center, Seattle
Donor Stem Cell Transplant With Treosulfan, Fludarabine, and Total-Body Irradiation for the Treatment of Hematological Malignancies
InaajiriHatua 2Wajitolea wenye afya wanakaribishwa
- Fred Hutch/University of Washington Cancer Consortium, Seattle
Sonrotoclax, Rituximab, and Zanubrutinib in Treating Participants With Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, and Mantle Cell Lymphoma
InaajiriHatua 2
- Fred Hutch/University of Washington Cancer Consortium, Seattle
Study of SGR-1505 in Mature B-Cell Neoplasms
InaajiriHatua 1
- Fred Hutchinson Cancer Center, Seattle
BAFFR-targeting CAR T Cells for Patients With Relapsed or Refractory B-NHL
InaajiriHatua 1
- Providence Swedish Cancer Institute, Seattle
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
InaajiriUtafiti wa uchunguzi
- Massive Bio SYNERGY-AI site, Seattle
A Study of AC676 for the Treatment of Relapsed/Refractory B-Cell Malignancies
InaajiriHatua 1
- Swedish Cancer Institute, Seattle
Majaribio ya Limfoma ya Seli za Mantle katika miji mingine
- Baldwin Park, CAUtafiti 15
- Houston, TXUtafiti 15
- Durham, NCUtafiti 13
- Milwaukee, WIUtafiti 12
- New York City, NYUtafiti 12
- Boston, MAUtafiti 11
- Columbus, OHUtafiti 11
- Nashville, TNUtafiti 11
- Chicago, ILUtafiti 10
- Portland, ORUtafiti 9
- Rochester, MNUtafiti 9
- St. Louis, MOUtafiti 8
Masomo mengine katika Seattle
- Saratani ya Mapafu Isiyo na Selu NdogoUtafiti 53
- Saratani (aina zote)Utafiti 49
- Saratani ya ProstateUtafiti 42
- Leukemia ya Myeloid ya GhaflaUtafiti 40
- Saratani ya MatitiUtafiti 39
- Saratani ya MetastasiUtafiti 39
- Kansari ya kolorektaliUtafiti 34
- Saratan ya MapafuUtafiti 33
- Kansari ya MayaiUtafiti 30
- Multiple MyelomaUtafiti 22
- Sindromu za MyelodysplasticUtafiti 21
- Leukemia ya Lymphoblastic ya GhaflaUtafiti 21
Kutoka ClinicalTrials.gov, data iliyopatikana 5 Okt 2026. Kila utafiti una masharti yake ya kufaa; timu ya utafiti huamua nani anaweza kujiunga.